GlassScriptPhysician profile
Brendan J Keys
NPI 1043296833
$722.76
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $616 · 2022: $107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $143.18 | 2021 | |
| Abbvie INC. | $119.63 | 2021 | |
| Novo Nordisk INC | $88.30 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $78.26 | 2022 | |
| Amgen INC. | $66.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.04 | 2021 | |
| Eisai INC. | $36.01 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.73 | 2021-2022 | |
| Glaxosmithkline, LLC. | $24.37 | 2021 | |
| Amarin Pharma, INC. | $20.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.41 | 2021 | |
| Lilly USA, LLC | $17.78 | 2021 | |
| Daiichi Sankyo INC. | $15.94 | 2021 | |
| Vistapharm, INC. | $13.84 | 2021 | |
| Pfizer INC. | $11.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Keys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.